Individualized model for predicting pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: A multicenter study

BACKGROUND: Pathological complete response (pCR) is considered a surrogate for favorable survival in breast cancer (BC) patients treated with neoadjuvant chemotherapy (NACT), which is the goal of NACT. This study aimed to develop and validate a nomogram for predicting the pCR probability of BC patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Bei, Yang, Jing, Zhou, Jun, Hu, Longqing, Zhang, Shoupeng, Ren, Min, Qu, Xincai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428399/
https://www.ncbi.nlm.nih.gov/pubmed/36060977
http://dx.doi.org/10.3389/fendo.2022.955250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428399/
https://www.ncbi.nlm.nih.gov/pubmed/36060977
http://dx.doi.org/10.3389/fendo.2022.955250

Ejemplares similares